Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
life sciences
national blog main
san francisco
3
×
san francisco blog main
san francisco top stories
boston blog main
cancer diagnostics
deals
new york blog main
san diego blog main
10x genomics
adeno-associated virus
alexandria venture investments
altitude life science ventures
american society of gene and cell therapy
arch venture partners
astellas pharma
becton dickinson
boston top stories
boxer capital
cancer
diagnostic device
dravet syndrome
ed kaye
encoded therapeutics
freenome
gene therapy
generation bio
grail
guardant health
hemophilia
idiopathic pulmonary fibrosis (ipf)
illumina
illumina ventures
liquid biopsy
lucence
lung cancer
lymphoma
matrix capital management
What
treatment
3
×
company
help
medicine
tests
adding
aims
announced
area
based
bay
biopsy
blood
buildout
cancer
close
crude
cutting
deal
decisions
despite
developing
diagnostic
diagnostics
edge
effects
encoded
expand
firm
fold
gene
genomic
illumina’s
lasting
limited
limits
liquid
long
lucence
make
Language
unset
Current search:
biotech
×
treatment
×
" san francisco "
×
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits